TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
5.26
-0.27 (-4.80%)
At close: Jan 20, 2026, 4:00 PM EST
5.26
0.00 (0.00%)
After-hours: Jan 20, 2026, 4:00 PM EST
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $262.81 million as of January 20, 2026. Its market cap has increased by 72.03% in one year.
Market Cap
262.81M
Enterprise Value
274.25M
1-Year Change
72.03%
Ranking
Category
Stock Price
$5.26
Market Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $262.81M, a decrease of -20.06%. That is a compound annual growth rate of -4.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 276.05M | -20.85% |
| Dec 31, 2025 | 348.75M | 128.28% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
| Feb 8, 2021 | 328.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |